The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.
about
Clinical trials and medical care: defining the therapeutic misconceptionHow numeracy influences risk comprehension and medical decision makingAdolescent perspectives on phase I cancer researchParental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview studyAn intervention to improve cancer patients' understanding of early-phase clinical trials.Promoting Factors and Barriers to Participation in Early Phase Clinical Trials: Patients Perspectives.Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium study.Timing of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study.A framework for health numeracy: how patients use quantitative skills in health care.Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials.Conceptual problems in laypersons' understanding of individualized cancer risk: a qualitative study.Evaluation of patient enrollment in oncology phase I clinical trials.Decision making and cancer.Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriersVisual aids improve diagnostic inferences and metacognitive judgment calibration.Understanding patients' attitudes toward communication about the cost of cancer care.Description of the types and content of phase 1 clinical trial consent conversations in practiceEmerging empirical evidence on the ethics of schizophrenia research.Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study.Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure.The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials.Cancer patient preferences for quality and length of lifeWhy is recruitment to trials difficult? An investigation into recruitment difficulties in an RCT of supported employment in patients with severe mental illness.Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consentClinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death.Research biopsies in phase I studies: views and perspectives of participants and investigators.Recommendations for enhancing clinical trials education: a review of the literature.A Qualitative Study of Decision-Making on Phase III Randomized Clinical Trial Participation in Pediatric Oncology: Adolescents' and Parents' Perspectives and Preferences.Understanding how coping strategies and quality of life maintain hope in patients deliberating phase I trial participation.Complexity Analysis of Decision-Making in the Critically Ill.Designing Visual Aids That Promote Risk Literacy: A Systematic Review of Health Research and Evidence-Based Design Heuristics.Is patients' numeracy related to physical and mental health?"Is a cure in my sight?" Multi-stakeholder perspectives on phase I choroideremia gene transfer clinical trials.Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option?Attitudes toward participating in Phase I clinical trials: an investigation with patient-family-physician triads.Development and Validation of the Spanish Numeracy Understanding in Medicine InstrumentLong-term mortality and quality of life after septic shock: a follow-up observational study.Referral Patterns of Gynecological Cancer Patients to a Palliative Medicine Unit: A 2 Years Retrospective Analysis.The experience of older patients with cancer in phase 1 clinical trials: a qualitative case series.Know the risk, take the win: how executive functions and probability processing influence advantageous decision making under risk conditions.
P2860
Q21144663-21B553EE-1C64-447D-A993-70D1F4E521E4Q24615211-4DF80016-6081-48FF-854A-26BDA1397966Q30531481-D5707138-2A6F-4BE5-8B7C-B72C3FE20FCBQ30539918-12A91B09-A33F-4ABA-9C09-FDE5531190B8Q33857722-FBDA1BA1-7FBF-4294-BA4C-875D8D761312Q33956979-DA931ABC-46EE-4C34-9332-51A872990111Q34027888-D8E5C338-582D-4C0D-A9BC-0A5416F37472Q34115856-F4740B0A-EC8F-49D8-8B36-EE6C58F46A94Q34172691-40EBF5B9-1F32-40C2-B064-4FF0584F1A5AQ34251038-8BE5085C-B5E3-4F40-8A45-1BBB173463F2Q34378266-0CD28AA3-15E0-40E0-9487-07F0527046B3Q34594562-6ADF0767-4E9B-4D50-9280-715ABAD3116FQ35142194-D32785B3-325A-4CC6-9BD1-D45A6A2CF6A0Q35563968-1640DD2F-2144-4C3C-85B5-67F29C6CDCACQ35856951-C63B9320-C0C4-4BD2-B213-78B89D372AA6Q36095282-DB8AA99A-2C48-469B-8480-22C91C371034Q36275979-5F09DD7C-1AE2-4973-B319-2ACBFC774222Q36291530-2C534069-E5B1-4224-97EA-B9C3F8E6AF06Q36552760-9534C6BC-78B0-40EC-A2C0-DAF899B0511DQ36758142-ED8C0727-D5CA-45F1-BAD7-A93780EA5041Q36818341-F1DBB99B-1109-4946-901C-267914AEB09CQ37023256-E20334D2-9379-44BB-B2DB-C9149FA7FAE0Q37061779-E39FCF40-C3D8-4EA2-997A-07F53B120AB3Q37071723-6503BB5D-2BA4-4E86-A468-6F00E425FF56Q37686819-BACAE3A2-335A-4E0B-B911-71C3EE4E1421Q37687469-B1D3F67F-9936-4668-98E6-7A6FAEFEE47EQ37791483-048CDFBC-894C-4CB3-8436-B89774A06B48Q38644166-AE14A855-D8F9-4D37-B896-DF4B0FF7CDD1Q38700608-4D964ECA-3BF7-4886-B68D-6A25AC5D0B88Q38792264-9BC2CE74-F91B-4542-BE6E-2E82B3252631Q38963948-BBD99EF2-745E-4C9A-90A3-D67556F3848DQ39010647-08C0E700-687E-4014-88C3-8FBD09970B74Q39526489-3F10B15E-A689-4E96-AC9F-DA0AB0D840FDQ40025547-4E7863DC-8730-4F59-B10A-D43C17B721F6Q40563636-BCC4FA41-9847-41FC-9EB4-3ED8CB709BB8Q42709625-9C16350A-119C-4C8F-A12E-BCC5E9B2B655Q44616820-34AFA271-C168-4FF9-AEC5-FB972D5B1E6DQ44712593-CA1CA7FB-6E40-40B3-BE6A-E8E8498E3304Q47616108-F070C79A-E5E9-4EF8-8F52-6564FC3DBAE8Q48064662-06F1DAD0-167B-4AB3-8F57-DA4A1D16286D
P2860
The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
The correlation between patien ...... from Phase I clinical trials.
@en
The correlation between patien ...... from Phase I clinical trials.
@nl
type
label
The correlation between patien ...... from Phase I clinical trials.
@en
The correlation between patien ...... from Phase I clinical trials.
@nl
prefLabel
The correlation between patien ...... from Phase I clinical trials.
@en
The correlation between patien ...... from Phase I clinical trials.
@nl
P2093
P356
P1433
P1476
The correlation between patien ...... from Phase I clinical trials.
@en
P2093
Al B Benson
Andrew M Balshem
Caroline B Burnett
Daniel P Sulmasy
Darrell J Gaskin
Elyse F Slater
John L Marshall
Kevin A Schulman
Kevin P Weinfurt
Liana D Castel
P304
P356
10.1002/CNCR.11483
P407
P577
2003-07-01T00:00:00Z